EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Loop Diuretic Use with Hospitalization with Atrial Fibrillation in CKD

Katherine Scovner Ravi iD, Armida LeFranc Torres iD, Finnian R Mc Causland iD

Kidney360 · 2026-10 · 7 (10) · 2274-2280

DOI: 10.34067/kid.0000001229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 15.05.2026. Verfasst von Katherine Scovner Ravi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mass General Brigham, and Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Atrial Fibrillation, Renal Insufficiency, Chronic, Hospitalization, Sodium Potassium Chloride Symporter Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Division of Diabetes, Endocrinology, and Metabolic Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points The use of loop diuretic medications was associated with a 34% higher risk of hospitalization with atrial fibrillation in patients with CKD. The association appeared stronger in patients with comorbid heart failure compared with those without. Future research is indicated to explore mechanisms and mitigate potential harms.

Background

CKD is associated with a high burden of cardiovascular complications, including atrial fibrillation. While loop diuretic medications are commonly prescribed for volume and BP management in CKD, their relationship with incident atrial fibrillation in this population remains poorly understood.

Methods

Using data from 4607 patients without baseline atrial fibrillation from the Chronic Renal Insufficiency Cohort, we used adjusted Cox regression models to explore the association of baseline loop diuretic use with hospitalization with atrial fibrillation. We tested for differential associations according to sex, history of heart failure, and baseline CKD stage category. Models adjusted for demographics, cardiovascular risk factors, kidney function (eGFR), laboratory parameters (albumin, hematocrit, log 24-hour urine protein), and the use of cardiovascular medications.

Results

The mean age of subjects at baseline was 59±11 years, 44% were female, and 42% were Black. The mean follow-up was 9.3 years, during which time 614 participants experienced a hospitalization with atrial fibrillation. Baseline loop diuretic therapy was associated with a 41% higher risk of hospitalization with atrial fibrillation (adjusted hazard ratio [aHR], 1.41; 95% confidence interval [CI], 1.14 to 1.73). There was no effect modification by sex or CKD stage ( P interactions = 0.52 and 0.29, respectively). The association appeared stronger among those with versus without heart failure (aHR, 3.00; 95% CI, 1.22 to 7.37 versus aHR, 1.33; 95% CI, 1.06 to 1.66), although the interaction did not reach statistical significance ( P interaction = 0.06).

Conclusions

Among patients with CKD and without a history of atrial fibrillation, the use of loop diuretics is independently associated with subsequent hospitalization with atrial fibrillation. This association appeared to be more potent among those with (versus without) a history of heart failure. The etiology of the observed association requires further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationRenal Insufficiency, ChronicHospitalizationSodium Potassium Chloride Symporter InhibitorsHumansFemaleMaleMiddle AgedAgedHeart FailureRisk Factors

Stichwörter der Autor:innen

CKDdiureticshypertension

Substanzen

Sodium Potassium Chloride Symporter Inhibitors

Autor:innen und Institutionen

  • Mass General Brigham, and Harvard Medical School, Boston, Massachusetts.

ORCID-Profile: Katherine Scovner Ravi, Armida LeFranc Torres, Finnian R Mc Causland

Förderung

  • NIDDK NIH HHS
  • Division of Diabetes, Endocrinology, and Metabolic Diseases

Zitieren

APA

Ravi, K. S., Torres, A. L., & Mc Causland, F. R. (2026). Association of Loop Diuretic Use with Hospitalization with Atrial Fibrillation in CKD. Kidney360, 7(10), 2274-2280. https://doi.org/10.34067/kid.0000001229

Vancouver

Ravi KS, Torres AL, Mc Causland FR. Association of Loop Diuretic Use with Hospitalization with Atrial Fibrillation in CKD. Kidney360. 2026;7(10):2274-2280. doi:10.34067/kid.0000001229

BibTeX
@article{Ravi2026,
  author = {Ravi, Katherine Scovner and Torres, Armida LeFranc and Mc Causland, Finnian R},
  title = {Association of Loop Diuretic Use with Hospitalization with Atrial Fibrillation in CKD},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {10},
  pages = {2274--2280},
  doi = {10.34067/kid.0000001229}
}
Kostenlos starten →